Genotoxicity of several clinically used topoisomerase II inhibitors

Author： Boos G.   Stopper H.  

Publisher： Elsevier

ISSN： 0378-4274

Source： Toxicology Letters, Vol.116, Iss.1, 2000-07, pp. : 7-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D-QSAR study on heterocyclic topoisomerase II inhibitors using CoMSIA†

By Tekiner-Gulbas B.   Temiz-Arpaci O.   Yildiz I.   Aki-Sener E.   Yalcin I.  

SAR and QSAR in Environmental Research, Vol. 17, Iss. 2, 2006-04 ,pp. : 121-132

Taylor & Francis Ltd

Access to resources Recommend Favorite

1,3-Butadiene: II. Genotoxicity profile

By Albertini Richard J.   Carson M. Leigh   Kirman Christopher R.   Gargas Michael L.  

Critical Reviews in Toxicology, Vol. 40, Iss. 1, 2010-10 ,pp. : 12-73

Informa Healthcare

Access to resources Recommend Favorite

Genotoxicity of mercury used in chromosome aberration tests

By Akiyama M.   Oshima H.   Nakamura M.  

Toxicology in Vitro, Vol. 15, Iss. 4, 2001-08 ,pp. : 463-467

Elsevier

Access to resources Recommend Favorite

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor

By Ezoe Sachiko  

International Journal of Environmental Research and Public Health, Vol. 9, Iss. 7, 2012-07 ,pp. : 2444-2453

MDPI

Access to resources Recommend Favorite

Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents

By Cowell Ian G.   Austin Caroline A.  

International Journal of Environmental Research and Public Health, Vol. 9, Iss. 6, 2012-05 ,pp. : 2075-2091

MDPI

Access to resources Recommend Favorite